The continuum of care: A paradigm for the management of metastatic colorectal cancer

Richard M. Goldberg, Mace L. Rothenberg, Eric Van Cutsem, Al B. Benson, Charles Blanke, Robert B. Diasio, Axel Grothey, Heinz Josef Lenz, Neal J. Meropol, Ramesh K. Ramanathan, Carlos H Roberto Becerra, Rita Wickham, Delma Armstrong, Carol Viele

Research output: Contribution to journalArticle

175 Citations (Scopus)

Abstract

New agents for the treatment of metastatic colorectal cancer have extended median overall survival to more than 20 months, an increase that has changed the view of advanced colorectal cancer from an acute to a chronic condition. This article proposes a shift in treatment strategy from the concept of successive "lines" of therapy, in which chemotherapy is continued until disease progression, to that of a continuum of care, in which the use of chemotherapy is tailored to the clinical setting and includes switching chemotherapy prior to disease progression, maintenance therapy, drug "holidays," and surgical resection of metastases in selected patients. In this approach, the distinction between lines of therapy is no longer absolute. This represents a paradigm shift in the management of metastatic colorectal cancer to that of a continuum of care approach that includes individualized planning, in which patients are given the opportunity to benefit from exposure to all active agents and modalities while minimizing unnecessary treatment and toxicity, with the ultimate goal of improving survival as well as quality of life.

Original languageEnglish (US)
Pages (from-to)38-50
Number of pages13
JournalOncologist
Volume12
Issue number1
DOIs
StatePublished - 2007

Fingerprint

Continuity of Patient Care
Colorectal Neoplasms
Drug Therapy
Disease Progression
Therapeutics
Holidays
Survival
Quality of Life
Neoplasm Metastasis

Keywords

  • Biologic therapy
  • Chemotherapy
  • Colorectal cancer

ASJC Scopus subject areas

  • Cancer Research
  • Hematology

Cite this

Goldberg, R. M., Rothenberg, M. L., Van Cutsem, E., Benson, A. B., Blanke, C., Diasio, R. B., ... Viele, C. (2007). The continuum of care: A paradigm for the management of metastatic colorectal cancer. Oncologist, 12(1), 38-50. https://doi.org/10.1634/theoncologist.12-1-38

The continuum of care : A paradigm for the management of metastatic colorectal cancer. / Goldberg, Richard M.; Rothenberg, Mace L.; Van Cutsem, Eric; Benson, Al B.; Blanke, Charles; Diasio, Robert B.; Grothey, Axel; Lenz, Heinz Josef; Meropol, Neal J.; Ramanathan, Ramesh K.; Becerra, Carlos H Roberto; Wickham, Rita; Armstrong, Delma; Viele, Carol.

In: Oncologist, Vol. 12, No. 1, 2007, p. 38-50.

Research output: Contribution to journalArticle

Goldberg, RM, Rothenberg, ML, Van Cutsem, E, Benson, AB, Blanke, C, Diasio, RB, Grothey, A, Lenz, HJ, Meropol, NJ, Ramanathan, RK, Becerra, CHR, Wickham, R, Armstrong, D & Viele, C 2007, 'The continuum of care: A paradigm for the management of metastatic colorectal cancer', Oncologist, vol. 12, no. 1, pp. 38-50. https://doi.org/10.1634/theoncologist.12-1-38
Goldberg, Richard M. ; Rothenberg, Mace L. ; Van Cutsem, Eric ; Benson, Al B. ; Blanke, Charles ; Diasio, Robert B. ; Grothey, Axel ; Lenz, Heinz Josef ; Meropol, Neal J. ; Ramanathan, Ramesh K. ; Becerra, Carlos H Roberto ; Wickham, Rita ; Armstrong, Delma ; Viele, Carol. / The continuum of care : A paradigm for the management of metastatic colorectal cancer. In: Oncologist. 2007 ; Vol. 12, No. 1. pp. 38-50.
@article{e4b19354559a40c49cbe98d51adf6fc3,
title = "The continuum of care: A paradigm for the management of metastatic colorectal cancer",
abstract = "New agents for the treatment of metastatic colorectal cancer have extended median overall survival to more than 20 months, an increase that has changed the view of advanced colorectal cancer from an acute to a chronic condition. This article proposes a shift in treatment strategy from the concept of successive {"}lines{"} of therapy, in which chemotherapy is continued until disease progression, to that of a continuum of care, in which the use of chemotherapy is tailored to the clinical setting and includes switching chemotherapy prior to disease progression, maintenance therapy, drug {"}holidays,{"} and surgical resection of metastases in selected patients. In this approach, the distinction between lines of therapy is no longer absolute. This represents a paradigm shift in the management of metastatic colorectal cancer to that of a continuum of care approach that includes individualized planning, in which patients are given the opportunity to benefit from exposure to all active agents and modalities while minimizing unnecessary treatment and toxicity, with the ultimate goal of improving survival as well as quality of life.",
keywords = "Biologic therapy, Chemotherapy, Colorectal cancer",
author = "Goldberg, {Richard M.} and Rothenberg, {Mace L.} and {Van Cutsem}, Eric and Benson, {Al B.} and Charles Blanke and Diasio, {Robert B.} and Axel Grothey and Lenz, {Heinz Josef} and Meropol, {Neal J.} and Ramanathan, {Ramesh K.} and Becerra, {Carlos H Roberto} and Rita Wickham and Delma Armstrong and Carol Viele",
year = "2007",
doi = "10.1634/theoncologist.12-1-38",
language = "English (US)",
volume = "12",
pages = "38--50",
journal = "Oncologist",
issn = "1083-7159",
publisher = "AlphaMed Press",
number = "1",

}

TY - JOUR

T1 - The continuum of care

T2 - A paradigm for the management of metastatic colorectal cancer

AU - Goldberg, Richard M.

AU - Rothenberg, Mace L.

AU - Van Cutsem, Eric

AU - Benson, Al B.

AU - Blanke, Charles

AU - Diasio, Robert B.

AU - Grothey, Axel

AU - Lenz, Heinz Josef

AU - Meropol, Neal J.

AU - Ramanathan, Ramesh K.

AU - Becerra, Carlos H Roberto

AU - Wickham, Rita

AU - Armstrong, Delma

AU - Viele, Carol

PY - 2007

Y1 - 2007

N2 - New agents for the treatment of metastatic colorectal cancer have extended median overall survival to more than 20 months, an increase that has changed the view of advanced colorectal cancer from an acute to a chronic condition. This article proposes a shift in treatment strategy from the concept of successive "lines" of therapy, in which chemotherapy is continued until disease progression, to that of a continuum of care, in which the use of chemotherapy is tailored to the clinical setting and includes switching chemotherapy prior to disease progression, maintenance therapy, drug "holidays," and surgical resection of metastases in selected patients. In this approach, the distinction between lines of therapy is no longer absolute. This represents a paradigm shift in the management of metastatic colorectal cancer to that of a continuum of care approach that includes individualized planning, in which patients are given the opportunity to benefit from exposure to all active agents and modalities while minimizing unnecessary treatment and toxicity, with the ultimate goal of improving survival as well as quality of life.

AB - New agents for the treatment of metastatic colorectal cancer have extended median overall survival to more than 20 months, an increase that has changed the view of advanced colorectal cancer from an acute to a chronic condition. This article proposes a shift in treatment strategy from the concept of successive "lines" of therapy, in which chemotherapy is continued until disease progression, to that of a continuum of care, in which the use of chemotherapy is tailored to the clinical setting and includes switching chemotherapy prior to disease progression, maintenance therapy, drug "holidays," and surgical resection of metastases in selected patients. In this approach, the distinction between lines of therapy is no longer absolute. This represents a paradigm shift in the management of metastatic colorectal cancer to that of a continuum of care approach that includes individualized planning, in which patients are given the opportunity to benefit from exposure to all active agents and modalities while minimizing unnecessary treatment and toxicity, with the ultimate goal of improving survival as well as quality of life.

KW - Biologic therapy

KW - Chemotherapy

KW - Colorectal cancer

UR - http://www.scopus.com/inward/record.url?scp=33846404530&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846404530&partnerID=8YFLogxK

U2 - 10.1634/theoncologist.12-1-38

DO - 10.1634/theoncologist.12-1-38

M3 - Article

C2 - 17227899

AN - SCOPUS:33846404530

VL - 12

SP - 38

EP - 50

JO - Oncologist

JF - Oncologist

SN - 1083-7159

IS - 1

ER -